Fairvalue-Calculator Fairvalue-Calculator
EN DE

Navamedic ASA (NAVA) Fair Value & Analysis

Healthcare · NO · Market cap 423M NOK

Pricekr 16.35
Fair Valuekr 19.40
Upside+18.7%
Quality95/100
Evidence: High Range kr 11.33 – kr 29.01

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Navamedic ASA (NAVA) currently trades at kr 16.35, while our model-based Fair Value estimate is kr 19.40 — implying the stock looks roughly 18.7% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. The company offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic and propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases, fat metabolism, renal, nutritional support, and ketogenic diet. In addition, it provides consumer health products consisting of non-prescription drugs and health care products for erectile dysfunction, pain, gastro-related problems, and others primarily through pharmacies and drugstores; prescription medicines coverin…

Open the full interactive analysis →

Similar stocks

McKesson Corporation (M1CK34) -81% Cencora, Inc (C1CO34) -89% Cardinal Health, Inc (CAH) -38% Sigma Healthcare Limited (SIGGF) -67% Sitka Gold Corp (SIG) -88% Shanghai Pharmaceuticals Holding (601607) +112%

Frequently asked questions

Is Navamedic ASA (NAVA) undervalued?
As of Jun 24, 2026, our model estimates a fair value of kr 19.40 versus a price of kr 16.35 — about +19% (undervalued). Model-based estimate, not financial advice.
What is the fair value of NAVA?
Our 21-model fair value for Navamedic ASA is kr 19.40 (as of Jun 24, 2026), built from audited fundamentals. The current price is kr 16.35.
What is the quality score of NAVA?
Navamedic ASA has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.